GLOBAL HEALTHCARE ACCESS CITIZENSHIP

GLOBAL HEALTHCARE ACCESS HIGHLIGHTS FROM FISCAL YEAR 2018

Technology is at the heart of everything we do. This year, our products and services improved the lives of more than 71 million people around the world. We worked to enhance patient experience and improve accuracy of treatment by embracing emerging solutions such as intelligent wearable and implanted devices, 3D printing, and augmented reality applications. We tested promising innovations using rigorous clinical trials to establish safety and effectiveness. In FY18 Medtronic:

• Invested US$2.3 billion in research and development (R&D).
• Launched 72 new clinical studies, completed 81 clinical studies, and had 320 clinical studies in progress.

To have large-scale impact, our products and therapies must be both effective and affordable. We worked to improve affordability while advocating for adoption of value-based healthcare models. To improve affordability and maximise value in FY18, we:

• Offered a variety of pricing models, including volume pricing or rebate options for hospitals, adaptive pricing for treating long-term conditions, and programs to assist new and existing patients.
• Worked to improve our products’ efficiency and effectiveness simultaneously, to achieve better outcomes at lower cost.
• Partnered with others to enhance economic value across global healthcare systems.

One way to improve global access to healthcare is to reimagine how we deliver care. Our efforts to improve care delivery included:

• Developing bold ideas for global health access that prioritise social impact alongside financial sustainability through Medtronic Labs. Shruti, a Medtronic Labs program, has screened over 390,000+ underserved residents in India for chronic ear infection. In addition, Medtronic Labs has trained more than 200 health workers.
• Investing US$139 million in capacity building and training for medical professionals (reaching a record 89,000 professionals) and US$33.8 million in patient education.
• Transforming how long-term needs are addressed in resource-constrained regions through a customised hub-and-spoke delivery model. In FY18, we used this model with a partner in India to develop a neuroscience center of excellence that will be the “hub” of a hub-and-spoke network, connected to 15 hospitals in the local area.
• Increasing access to real-time data through products, services, and solutions that tap into remote monitoring, wearables, and telehealth, such as Medtronic Care Management Services, Integrated Health Solutions, and our CareLink network, which connects cardiac patients with their care teams via the data recorded by our implantable cardiac devices. Now on its 15^th anniversary, CareLink has served more than 1.6 million patients in 15,000 clinics across 82 countries to date.

Featured Stories